Date published: 2026-5-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

IL-12Rβ2 Inhibitors

IL-12Rβ2 inhibitors are a group of chemical entities that belong to the realm of bioactive molecules aiming to intricately modulate the IL-12Rβ2 receptor's functionality. The IL-12Rβ2 receptor itself is an integral component of the immune system, specifically involved in orchestrating the cellular responses induced by interleukin-12 (IL-12), a pivotal cytokine in immune regulation. These inhibitors are meticulously designed with an emphasis on their three-dimensional structural configuration to ensure precise recognition and binding to the IL-12Rβ2 receptor's binding site. In terms of their mode of action, IL-12Rβ2 inhibitors interact with the receptor in a competitive or allosteric manner, with a prime objective of obstructing the IL-12 cytokine from engaging with its corresponding receptor. This interaction subsequently results in a disruption of the downstream signaling cascades typically instigated by the IL-12 and IL-12Rβ2 binding event. This targeted intervention ultimately influences the complex interplay of immune responses, leading to intricate alterations in cytokine-mediated cell communication and immune cell activation.

The intricate molecular design of IL-12Rβ2 inhibitors is a product of meticulous research and structure-activity relationship studies, aimed at achieving optimal binding affinity and selectivity for the receptor. This tailored binding affinity enables the inhibitors to effectively outcompete IL-12 for receptor binding, thereby acting as molecular impediments to the initiation of downstream immunomodulatory pathways. The quest to develop effective IL-12Rβ2 inhibitors has unveiled a deeper understanding of the delicate mechanisms that govern immune response regulation. By manipulating the interactions between cytokines and their cognate receptors, this class of inhibitors holds the potential to shed light on the dynamics of immune homeostasis and inflammation. Furthermore, their molecular specificity and mode of action make them a potent tool in the exploration of immune system modulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Baricitinib

1187594-09-7sc-364730
sc-364730A
5 mg
25 mg
$200.00
$664.00
(1)

An experimental IL-12Rβ2 monoclonal antibody by Eli Lilly for autoimmune and inflammatory diseases.